Clinical and Experimental Rheumatology
Overview
Clinical and Experimental Rheumatology is a peer-reviewed medical journal that focuses on the latest research and advancements in the field of rheumatology. It publishes original articles, reviews, and case reports, providing a platform for clinicians and researchers to share their findings and contribute to the understanding and management of rheumatic diseases.
Details
Details
Abbr.
Clin Exp Rheumatol
Start
1983
End
Continuing
Frequency
Bimonthly
p-ISSN
0392-856X
e-ISSN
1593-098X
Country
Italy
Language
English
Specialty
Rheumatology
Metrics
Metrics
h-index / Ranks: 2718
108
SJR / Ranks: 4434
907
CiteScore / Ranks: 3323
6.50
JIF / Ranks: 2561
3.7
Recent Articles
1.
Bauer Ventura I, Goldberg M, Schiffenbauer A, Shi M, Volochayev R, Jackson S, et al.
Clin Exp Rheumatol
. 2025 Mar;
43(3):552.
PMID: 40072873
No abstract available.
2.
Elia A, Zucchi D, Silvagni E, Oliva M, Cascarano G, Cardelli C, et al.
Clin Exp Rheumatol
. 2025 Mar;
43(3):397-406.
PMID: 40072872
This review highlights key advancements in systemic lupus erythematosus (SLE) research during 2024, covering pathogenesis, novel therapies, biomarkers, and clinical outcomes. Notable findings include new insights into immune dysregulation, promising...
3.
Perrin C, Coutts M
Clin Exp Rheumatol
. 2025 Mar;
43(3):550-551.
PMID: 40072871
No abstract available.
4.
Cheng S, Xu K, Hou W, Qin X, Liu L, Yang X, et al.
Clin Exp Rheumatol
. 2025 Mar;
43(3):459-466.
PMID: 40072870
Objectives: The genetic underpinnings of RA remain partially elucidated, motivating our exploration of copy number variations (CNV) and rare variations in the pathogenesis of RA. Methods: We conducted an integrated...
5.
Salam S, Morrow J, McDermott M, Zafeiropoulos N, Thornton J, Shah S, et al.
Clin Exp Rheumatol
. 2025 Feb;
43(2):334-344.
PMID: 40018748
Objectives: To investigate the intramuscular effects of arimoclomol using quantitative magnetic resonance imaging (qMRI) of the thighs in a subset of inclusion body myositis (IBM) participants from a multicentre, randomised,...
6.
Needham M, Badrising U, Beer K, Heim A, Doverty A, Panicker A, et al.
Clin Exp Rheumatol
. 2025 Feb;
43(2):309-315.
PMID: 40018747
Objectives: This paper aims to provide insight into the challenges and opportunities of conducting an investigator-led, international, multicentre clinical trial for Inclusion Body Myositis (IBM), a rare inflammatory myopathy. Methods:...
7.
Badrising U, Henderson R, Reddel S, Corbett A, Liang C, Reardon K, et al.
Clin Exp Rheumatol
. 2025 Feb;
43(2):316-325.
PMID: 40018746
Objectives: Inclusion body myositis (IBM) is a complex inflammatory muscle disease in adults over 40, with histological features of autoinflammation, cell stress and autophagic abnormalities, and marked clinically by relentless...
8.
Infections as a predominant cause of death in adult patients with idiopathic inflammatory myopathies
Opinc-Rosiak A, Kulesza E, Mikosinska A, Brzezinska O, Makowska J
Clin Exp Rheumatol
. 2025 Feb;
43(2):290-299.
PMID: 40018745
Objectives: To evaluate causes of death in the single-centre Polish cohort of patients with idiopathic inflammatory myopathies (IIM) and to identify risk factors associated with fatal outcomes. Methods: Electronic medical...
9.
Fattorini F, Conticini E, Dourado E, Bottazzi F, Bruno L, Diomedi M, et al.
Clin Exp Rheumatol
. 2025 Feb;
43(2):167-177.
PMID: 40018744
Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of autoimmune diseases characterised by skeletal muscle inflammation and frequently by other organs involvement, in particular lung and skin, but also joints,...
10.
Mok C, Leung M, Chan K, Ying K, Ho T, Lao W, et al.
Clin Exp Rheumatol
. 2025 Feb;
PMID: 39977029
Objectives: To study the safety and efficacy of tixagevimab-cilgavimab (TIX-CIL) in reducing COVID-19 in patients with rheumatic diseases receiving rituximab. Methods: Patients with rheumatic diseases who were receiving rituximab for...